ReviewSaudi medical journal2016

A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes.

Khalid Z Alshali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.